Food and Drug Administration (FDA) Commissioner Scott Gottlieb announced his resignation Tuesday, the Washington Post reports. His resignation will reportedly go into effect in about a month.
Gottlieb took over the post in May 2017, and in his time as the agency’s chief focused heavily on addressing key public health issues including youth vaping and opioid addiction, according to the report.
In his resignation letter, Gottlieb described the agency as having been “strong in moments of crisis.”
Former FDA chief Robert Califf said Gottlieb did “a great job” in his post.
To read the full report on the Washington Post, click here.